GA
Gagnon Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.1M | Buy |
213,402
+80,012
| +60% | +$1.91M | 3.43% | 14 |
|
|
2025
Q1 | $3.31M | Hold |
133,390
| – | – | 2.34% | 19 |
|
|
2024
Q4 | $2.51M | Hold |
133,390
| – | – | 1.61% | 23 |
|
|
2024
Q3 | $2.01M | Hold |
133,390
| – | – | 1.3% | 24 |
|
|
2024
Q2 | $3.82M | Hold |
133,390
| – | – | 2.91% | 19 |
|
|
2024
Q1 | $3.9M | Hold |
133,390
| – | – | 3.38% | 15 |
|
|
2023
Q4 | $4.5M | Sell |
133,390
-46,941
| -26% | -$1.58M | 3.93% | 14 |
|
|
2023
Q3 | $5.53M | Hold |
180,331
| – | – | 4.63% | 10 |
|
|
2023
Q2 | $7.23M | Hold |
180,331
| – | – | 4.84% | 9 |
|
|
2023
Q1 | $7.36M | Hold |
180,331
| – | – | 4.94% | 7 |
|
|
2022
Q4 | $6.96M | Hold |
180,331
| – | – | 4.7% | 10 |
|
|
2022
Q3 | $9.59M | Sell |
180,331
-55,114
| -23% | -$2.93M | 6.21% | 3 |
|
|
2022
Q2 | $13.7M | Sell |
235,445
-15,695
| -6% | -$915K | 8.31% | 1 |
|
|
2022
Q1 | $19.2M | Hold |
251,140
| – | – | 8.83% | 1 |
|
|
2021
Q4 | $15.1M | Buy |
251,140
+10,998
| +5% | +$662K | 6% | 2 |
|
|
2021
Q3 | $13.4M | Buy |
240,142
+26,925
| +13% | +$1.51M | 5.33% | 5 |
|
|
2021
Q2 | $12.9M | Buy |
213,217
+19,357
| +10% | +$1.17M | 4.92% | 6 |
|
|
2021
Q1 | $13.6M | Hold |
193,860
| – | – | 5.59% | 4 |
|
|
2020
Q4 | $11.6M | Hold |
193,860
| – | – | 5.21% | 6 |
|
|
2020
Q3 | $11.7M | Hold |
193,860
| – | – | 7.15% | 3 |
|
|
2020
Q2 | $10.2M | Hold |
193,860
| – | – | 7.32% | 4 |
|
|
2020
Q1 | $6.5M | Hold |
193,860
| – | – | 6.07% | 4 |
|
|
2019
Q4 | $8.78M | Hold |
193,860
| – | – | 4.92% | 8 |
|
|
2019
Q3 | $7.38M | Buy |
193,860
+86,448
| +80% | +$3.29M | 4.58% | 7 |
|
|
2019
Q2 | $4.67M | Buy |
+107,412
| New | +$4.67M | 2.67% | 21 |
|